Carilizumab and Albumin Paclitaxel for Second-line Treatment of Advanced Gastric Cancer
Clinical trial NCT07320586 · RECRUITING
Trial details
- NCT number
- NCT07320586
- Sponsor
- Shandong Tumor Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-01
- Primary completion
- 2026-06-30
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.